Vazegepant HCl
CAS No. 1414976-20-7
Vazegepant HCl ( —— )
Catalog No. M22411 CAS No. 1414976-20-7
Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 215 | Get Quote |
|
10MG | 317 | Get Quote |
|
25MG | 536 | Get Quote |
|
50MG | 763 | Get Quote |
|
100MG | 1053 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVazegepant HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionVazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
-
DescriptionVazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1414976-20-7
-
Formula Weight675.3
-
Molecular FormulaC36H47ClN8O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](Cc1cc(C)c2[nH]ncc2c1)NC(=O)N1CCC(CC1)c1cc2ccccc2[nH]c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moreno-Ajona D , Abigail Pérez-Rodríguez, Goadsby P J . Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment[J]. Current Opinion in Neurology, 2020, 33(3):1.
molnova catalog
related products
-
1-Deoxymannojirimyci...
1-Deoxymannojirimycin hydrochloride is a selective α1,2-mannosidase inhibitor(IC50: 20 μM). 1-Deoxymannojirimycin hydrochloride also inhibits HIV‐1 strains and has poor antiviral activity.
-
VUT-MK142
VUT-MK142 is a new cardiomyogenic small molecule promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes,which may be useful to differentiate stem cells into cardiomyocytes for cardiac repair.VUT-MK142 was identified as the most promising candidate with respect to cardiomyogenic activity.?
-
Bis(4-nitrophenyl)ph...
Bis(4-nitrophenyl)phosphate, sodium salt is a PDE (Phosphodiesterase) substrate.